PRESS RELEASE published on 12/22/2025 at 07:00, 7 months 15 days ago Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate Ipsen expands pipeline with Simcere Zaiming's novel antibody drug conjugate SIM0613 targeting LRRC15 protein for enhanced tumor penetration and anti-tumor activity. Phase I expected in H2 2026 Ipsen Antibody Drug Conjugate SIM0613 Simcere Zaiming LRRC15
BRIEF published on 12/05/2025 at 07:03, 8 months 1 day ago Transfer of Beech Tree shares to the Alasol Foundation by Ipsen Share Transfer Ipsen Henri Beaufour Beech Tree Alasol Foundation
PRESS RELEASE published on 12/05/2025 at 06:58, 8 months 1 day ago Ipsen provides update on legacy of Henri Beaufour Ipsen provides update on the transfer of Beech Tree shares to the Alasol Foundation following the passing of Henri Beaufour, Ipsen's Board Member, to support education for disadvantaged children and young adults Education Ipsen Henri Beaufour Alasol Foundation Beech Tree Shares
BRIEF published on 12/01/2025 at 07:05, 8 months 5 days ago Ipsen Announces the Passing of Henri Beaufour Business Development Board Member Ipsen Henri Beaufour Corporate Legacy
PRESS RELEASE published on 12/01/2025 at 07:00, 8 months 5 days ago Ipsen mourns the passing of Henri Beaufour, a founding family Board member Ipsen announces the passing of Henri Beaufour, a founding family Board member, with heartfelt condolences. Beech Tree and Highrock affirm support for Ipsen's future development Development Condolences Ipsen Henri Beaufour Founding Family
BRIEF published on 10/22/2025 at 07:10, 9 months 15 days ago Ipsen Reports Strong Sales and Raises 2025 Guidance Oncology Pipeline Therapeutic Areas 2025 Financial Guidance Ipsen Sales Growth ImCheck Acquisition
PRESS RELEASE published on 10/22/2025 at 07:05, 9 months 15 days ago Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance Ipsen reports strong sales growth in first nine months of 2025, upgrades full-year guidance, and announces acquisition of ImCheck Therapeutics. Financial results and pipeline updates detailed Acquisition Sales Growth Upgrades Full-year Guidance Ipsen
PRESS RELEASE published on 10/07/2025 at 18:30, 9 months 30 days ago IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025
PRESS RELEASE published on 09/16/2025 at 18:30, 10 months 20 days ago IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025
PRESS RELEASE published on 08/19/2025 at 18:00, 11 months 18 days ago IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2025
Published on 08/06/2026 at 23:15, 1 hour 7 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 2 hours 7 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 2 hours 17 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 2 hours 22 minutes ago Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE
Published on 08/06/2026 at 15:00, 9 hours 22 minutes ago Norsemont Strategically Expands Choquelimpie Land Package To 9,048 Hectares
Published on 08/06/2026 at 22:15, 2 hours 7 minutes ago BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 2 hours 36 minutes ago FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 5 hours 16 minutes ago Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 5 hours 57 minutes ago EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026
Published on 08/06/2026 at 18:26, 5 hours 56 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 17:45, 6 hours 37 minutes ago Declaration of voting rights at the end of July 2026
Published on 08/06/2026 at 17:35, 6 hours 47 minutes ago Groupe des Assurances du Crédit Mutuel (GACM)’s Solvency II ratio was 227% as of June 30, 2026
Published on 08/06/2026 at 17:35, 6 hours 47 minutes ago Availability of the financial statements of Groupe des Assurances du Crédit Mutuel for the first half of 2026